From: The innate immune response to ischemic injury: a multiscale modeling perspective
 | DAMPs | M1 | M2 | ROS | CCL2 | TRIF | CD13 | IRF3 | INFb | MyD88 | pIRAK | NF- kB | Intracellular steady state (from Table 4) | Tissue steady state (from Table 7) | ***% injury resolved or unresolved | references |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WT | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 1 | 100%–0% | [49] |
MyD88 KO | 1 | ND | ND | 0 | 0 | ND | 1 | ND | ND |  | 0 | 0 | 3 or 4 | 1 or 3* | 66%–33% | |
IRAK KO | 1 | ND | ND | 0 | 0 | 1 | 1 | ND | ND | 1 | – | 0 | 3 or 4 | 1 or 3* | 66%–33% | |
CCL2 KO | 1 | ND | ND | 0 | – | 1 | 1 | ND | ND | 1 | 1 | 1 | 3 or 4 | 1 or 3* | 66%–33% | |
TRIF KO | 1 | ND | ND | 0 | 1 | – | 1 | 0 | 0 | 1 | 1 | 1 | 6 | 1** | 100%–0% | |
CD13 KO | 2 | 1 | 1 | 1 | 1 | 2 |  | 2 | 2 | 1 | 1 | 1 | 6 | 1 | 100%–0% | [49] |